Evidence of an endogenous ouabain-like immunoreactive compound with digitalis-like properties in the human.
Balzan
S
S
CNR Institute of Clinical Physiology, University of Pisa, Italy.
Montali
U
U
Ghione
S
S
D001685:Biological Factors / Q000097:blood* / Q000302:isolation & purification / Q000494:pharmacology; D002298:Cardenolides; D002851:Chromatography, High Pressure Liquid; D004077:Digoxin; D004791:Enzyme Inhibitors / Q000494:pharmacology; D004912:Erythrocytes / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D007231:Infant, Newborn; D010042:Ouabain / Q000494:pharmacology*; D011863:Radioimmunoassay; D012413:Rubidium / Q000097:blood; D012503:Saponins / Q000097:blood / Q000302:isolation & purification / Q000494:pharmacology; D000254:Sodium-Potassium-Exchanging ATPase / Q000037:antagonists & inhibitors
D001685:Biological Factors; D002298:Cardenolides; D004791:Enzyme Inhibitors; D012503:Saponins; C034504:digoxin-like factors; D010042:Ouabain; D004077:Digoxin; D000254:Sodium-Potassium-Exchanging ATPase; D012413:Rubidium